"The Harvard Vanguard Kenmore practice has been caring for residents of Boston, Brookline, Roxbury and other nearby cities and towns since 1979. The office is conveniently located in the Kenmore Square area, on Brookline Avenue near Fenway Park. Our Kenmore practice provides primary care for adults and children and a full range of medical and surgical specialty care. Our preferred hospital partners include Beth Israel Deaconess Medical Center, Boston Children’s Hospital, Mount Auburn Hospital and New England Baptist Hospital."

During the past decade, Harvard Vanguard Medical Associates conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 4 clinical trials were completed, i.e. on average, 80% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Harvard Vanguard Medical Associates" #1 sponsor was "University of Pennsylvania" with 3 trials, followed by "Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)" with 2 trials sponsored, "Pfizer" with 2 trials sponsored, "ThromboGenics" with 2 trials sponsored and "Beth Israel Deaconess Medical Center" with 2 trials sponsored. Other sponsors include 9 different institutions and companies that sponsored additional 19 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Harvard Vanguard Medical Associates" #1 collaborator was "Harvard Vanguard Medical Associates" with 6 trials as a collaborator, "National Cancer Institute (NCI)" with 5 trials as a collaborator, "Brigham and Women's Hospital" with 3 trials as a collaborator, "Geisinger Clinic" with 2 trials as a collaborator and "Harvard School of Public Health (HSPH)" with 2 trials as a collaborator. Other collaborators include 8 different institutions and companies that were collaborators in the rest 18 trials.

According to Clinical.Site data, the most researched conditions in "Harvard Vanguard Medical Associates" are "Parkinson's Disease" (3 trials), "Colorectal Cancer" (2 trials), "Obesity" (2 trials), "Age Related Macular Degeneration" (1 trials) and "Anxiety" (1 trials). Many other conditions were trialed in "Harvard Vanguard Medical Associates" in a lesser frequency.

Most popular intervention types in "Harvard Vanguard Medical Associates" are "Behavioral" (8 trials), "Drug" (7 trials), "Other" (5 trials) and "Procedure" (4 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "fecal occult blood test" (2 trials), "screening colonoscopy" (2 trials), "2 mg perampanel" (1 trials) and "4 mg perampanel" (1 trials). Other intervention names were less common.

The vast majority of trials in "Harvard Vanguard Medical Associates" are 22 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Harvard Vanguard Medical Associates". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 20 completed trials in Harvard Vanguard Medical Associates, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Harvard Vanguard Medical Associates, 1 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 9 trials that are defined as “Not Applicable".